Alejandro Minguez
Overview
Explore the profile of Alejandro Minguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minguez A, Coello E, Garrido A, Ripoll P, Gomez M, Aguas M, et al.
Gastroenterol Hepatol
. 2024 Sep;
:502253.
PMID: 39270973
Background And Aims: Ustekinumab is an effective treatment for inflammatory bowel diseases. However, some patients do not respond to conventional doses. The aim of the study was to evaluate the...
2.
Plaza J, Minguez A, Bastida G, Marques R, Nos P, Poveda J, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612528
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the digestive tract usually characterized by diarrhea, rectal bleeding, and abdominal pain. IBD includes Crohn's disease and ulcerative colitis as...
3.
Minguez A, Conde I, Monton C, Gonzalez L, Pascual S, Anton M, et al.
Dig Dis Sci
. 2024 Mar;
69(5):1863-1871.
PMID: 38517562
Background And Aims: Recent studies point out to epidemiological changes in primary sclerosing cholangitis (PSC). Our aims were to determine in PSC patients followed in several centers in a Mediterranean...
4.
Mesonero F, Zabana Y, Fernandez-Clotet A, Leo-Carnerero E, Caballol B, Nunez-Ortiz A, et al.
Therap Adv Gastroenterol
. 2024 Mar;
17:17562848241234476.
PMID: 38445247
Background: The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders. Objective: To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch...
5.
Iborra M, Ferreiro-Iglesias R, Maria Dolores M, Mesonero Gismero F, Minguez A, Porto-Silva S, et al.
Scand J Gastroenterol
. 2023 Nov;
59(3):260-268.
PMID: 37933161
Objective: Ustekinumab was recently approved for the treatment of moderate-to-severe ulcerative colitis (UC). Although data from the UNIFI clinical trial are encouraging, real-world data assessing effectiveness and safety are scarce....
6.
Bastida G, Minguez A, Nos P, Moret-Tatay I
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36980826
The immune system and environmental factors are involved in various diseases, such as inflammatory bowel disease (IBD), through their effect on genetics, which modulates immune cells. IBD encompasses two main...
7.
Minguez A, Ladron P, Martinez S, Del Val A, Nos P, de-Madaria E
Gastroenterol Hepatol
. 2022 Oct;
46(4):297-304.
PMID: 36243251
Background: Choledocholithiasis causing acute biliary pancreatitis (ABP) may migrate to the duodenum or persist in the common bile duct (CBD). We developed a model for predicting persistent choledocholithiasis (PC) in...
8.
Martinez Delgado S, Minguez A, Bustamante M, Ladron Abia P, Lopez Munoz P, Pons Beltran V
Gastroenterol Hepatol
. 2022 May;
46(3):201-202.
PMID: 35569543
No abstract available.